I'll explain why I'm in no hurry. Time is relevant to what your goal is; if one is interested in a certain gain within a certain amount of time then their frustrations are related to that. If one's goal is to have DCVax-L approved by the FDA for treatment of GBM then that is dependent upon many variables, as we've seen. If for some reason nothing happens with combos, Direct, AND DCVax-L keeps getting pushed further back then I may change my mind.
But I feel that anyone who's dispassionate and really looks at the situation it's easy to see this is complex as hell and that they're inventing a pathway for themselves under new circumstances with data that is already mostly mature enough. This is not a company that has had the opportunity to have seen other immune vaccinations be approved by the FDA under the new standards and then went about designing a trial to meet those standards. It's a company with potentially ground breaking data that now is tasked with finding the best way to analyze that data so that it can be approved. You can put a timeline on it if you want, but I'm playing it strictly by ear and by what is shown publicly. Until I find much more to not trust management given what I see I'm sticking with them. Quite simple for me.
Every single time they've mentioned anything positive it's been met with a strike down of the share price. Anyone who believes they're going to allow themselves to be attacked again with anything remotely "time line"-like I feel is going to be disappointed. Frankly, I don't blame the company for not trusting anyone.
News 
Market Data 
Discover 
